SEC Form 4 · accession 0001179110-19-000877
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason N Gorevic
Officer — Chief Executive Officer · Director
Period of report
Jan 18, 2019
Accepted (ET)
Jan 23, 2019 · 4:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 18, 2019 | M | 30,000 | $1.07 | A | 633,719 | D | |
| Common StockF1,F2 | Jan 18, 2019 | S | 30,000 | $63.04 | D | 603,719 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $1.07 | Jan 18, 2019 | M | 30,000 | D | — | Apr 16, 2022 | Common Stock | 30,000 | 28,156 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018.
- F2Represents the weighted average price of transactions ranging from $61.56 to $64.22. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016.